I provide independent and original analysis, pricing metrics and recommendations for the stem, cell, gene and regenerative therapy equities.

Cytori (CYTX) 8.6 M share offering priced at $1.10 after stock jumps on BARDA news

April 10, 2017

  After a 25.55% (+$0.35) advance, CYTX launched a secondary offering.  Share pricing fell -34.30% (-$0.61) at the open  

Capricor Therapeutics (CAPR) at-the-market offering of $5 M

April 1, 2017

  CAPR closed up +$0.16 to $3.38, expect depreciation and dilution